NDA[removed]S-158 Page 3 Heparin Sodium Injection, USP Rx only DESCRIPTION

First Page		Document Content
Date: 2009-03-31 14:52:43 Heparins Coagulation system Low molecular weight heparin Thrombocytopenia Anticoagulant Deep vein thrombosis Protamine sulfate Platelet Factor X Blood Hematology Medicine		NDA[removed]S-158 Page 3 Heparin Sodium Injection, USP Rx only DESCRIPTION Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 232,47 KB Share Document on Facebook

	M118, A NOVEL, RATIONALLY ENGINEERED LOW MOLECULAR WEIGHT HEPARIN, WITH POTENT ANTI-XA AND ANTI-IIA ACTIVITIES IS REVERSIBLE BY PROTAMINE SULFATE, AND MONITORABLE WITH ACT FOLLOWING MULTIPLE IV INJECTIONS I. Fier , M. A DocID: 19U9M - View Document
	Figure 2: Mean ACT with Increasing Dose of M118 DocID: 19obY - View Document
	PLEASE TYPE POLICY TITLE HERE DocID: 17xHv - View Document
	Common drug is re-engineered to improve surgery outcomes DocID: 10EsE - View Document
	Monitoring of heparin and its low-molecular-weight analogs by silicon field effect Nebojsˇa M. Milovic´, Jonathan R. Behr, Michel Godin, Chih-Sheng Johnson Hou†, Kristofor R. Payer‡, Aarthi Chandrasekaran, Pete DocID: ZYn8 - View Document